ARTICLE | Company News
Takeda acquiring Inviragen
May 9, 2013 1:10 AM UTC
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will acquire infectious disease company Inviragen Inc. (Fort Collins. Colo.) for $35 million in cash up front, plus up to $215 million in milestones. Invira...